LEGN
Legend Biotech Corp
18.80$
+1.1%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -63.4% | -120.4% | 16.5% | -0.9% | -47.3% | -44.0% | -53.2% | -5.1% | 10.6% | -34.5% | -28.0% | -5.4% | -14.4% | |
| 5.4% | 6.7% | 6.1% | 2.9% | 2.4% | 3.6% | 2.7% | 2.3% | 2.2% | 3.9% | 5.1% | 3.0% | 3.6% | |
| 12.9% | 15.8% | 19.9% | 11.7% | 9.4% | 7.2% | 8.2% | 7.3% | 5.5% | 4.9% | 6.3% | 4.5% | 5.2% | |
| -1.9% | -14.6% | 100.1% | 1.6% | 1.2% | -42.9% | -37.7% | -14.3% | 28.3% | -10.2% | -24.8% | -25.9% | -10.2% | |
| 5.7% | 8.6% | 6.6% | 1.8% | 1.3% | 1.3% | 1.0% | 3.6% | 1.8% | 6.8% | 8.5% | 5.3% | 5.7% | |
| -217.8% | 512.8% | -421.5% | -372.9% | 205.4% | -47.1% | 131.6% | -64.9% | -7.3% | 209.0% | -55.2% | -31.0% | 26.1% | |
| – | – | – | – | -0.7% | -0.5% | -0.4% | -0.5% | -0.2% | -0.3% | -0.4% | -11.6% | -3.8% | |
| 1.0% | 1.2% | 0.9% | 0.5% | 2.6% | -0.2% | 0.3% | -0.4% | 0.2% | -0.2% | -0.4% | 43.3% | 13.1% | |
| -280.9% | 395.5% | -404.4% | -373.3% | 161.1% | -92.5% | 79.4% | -68.7% | 4.5% | 203.3% | -83.7% | 6.8% | 32.0% | |
| -69.1% | -129.0% | 9.9% | -2.7% | -48.6% | -45.3% | -54.2% | -8.7% | 8.7% | -41.3% | -36.5% | -10.7% | -20.1% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.